pivalylbenzhydrazine has been researched along with iproniazid in 3 studies
*Iproniazid: An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity. [MeSH]
*Iproniazid: An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DIGHIERO, J; HAZAN, J; RUDOLF, J | 1 |
ABRAMS, WB; BECKER, MC; KILLOUGH, JH; LEWIS, DW | 1 |
CALATAYUD, JB; ORVIS, HH; PRANDONI, AG | 1 |
3 other study(ies) available for pivalylbenzhydrazine and iproniazid
Article | Year |
---|---|
[Clinical study of a derivative of iproniazid, tersavid, in the treatment of angina pectoris].
Topics: Angina Pectoris; Biomedical Research; Iproniazid; Propionates | 1960 |
Amine oxidase inhibitors in the treatment of angina pectoris; preliminary report on marplan and tersavid.
Topics: Amines; Angina Pectoris; Humans; Iproniazid; Oxidoreductases; Propionates | 1960 |
Double-blind evaluation of an iproniazid analog (Ro 4-1634) in the treatment of angina pectoris.
Topics: Angina Pectoris; Double-Blind Method; Iproniazid; Propionates | 1961 |